XML 45 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
Organization and Business Operations (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Nov. 15, 2016
Jul. 31, 2016
Apr. 30, 2016
Feb. 29, 2016
Nov. 30, 2016
Jul. 31, 2016
Mar. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Common stock, issued             97,099,877 89,771,379 58,392,827
Accounts payable             $ 618,756 $ 663,261 $ 10,980
Accrued expenses             717,547 1,393,521 64,688
Due to related party             200,333 83,166 59,525
Accrued Interest Payable             21,225 14,475  
Issuance of common stock, shares     470,000 210,000          
Issuance of common stock, value   $ 15,000 $ 75,000 $ 60,000     $ 250,000 $ 1,000,000
Warrant[Member]                  
Warrants to purchase shares             300,000 300,000  
Stock price             $ 0.28 $ 0.15  
Warrant[Member] | Minimum [Member]                  
Fair value of exercise price per share             $ 0.28 $ 0.28  
Fair value of volatility rate             123.00% 121.00%  
Fair value of contractual lives             2 years 6 months 2 years 6 months  
Fair value of risk free rates             0.62% 0.62%  
Warrant[Member] | Maximum [Member]                  
Issuance of common stock, shares             3,153,211 3,153,211  
Fair value of exercise price per share             $ 0.75 $ 0.75  
Fair value of volatility rate             184.00% 157.00%  
Fair value of contractual lives             6 years 6 years  
Fair value of risk free rates             1.93% 1.93%  
Line Letter [Member] | Chairman Of Board [Member]                  
Line of credit current borrowing capacity $ 540,000             $ 250,000  
Line of credit maturity date Apr. 30, 2017                
Line Letter [Member] | Trieu [Member]                  
Line of credit $ 250,000           $ 475,064    
Line of credit, percentage 5.00%                
Debt conversion description Dr. Trieu has the right, exercisable by delivery of written notice thereof (the “Election Notice”), to either: (i) receive repayment for the entire unpaid principal amount advanced under the Line Letter and the accrued and unpaid interest thereon on the date of the delivery of the Election Notice (the “Outstanding Balance”) or (ii) convert the Outstanding Balance into such number of shares of our common stock as is equal to the quotient obtained by dividing (x) the Outstanding Balance by (y) $0.10 (such price, the “Conversion Price”); provided, that in no event shall the Conversion Price be lower than the lower of (x) $0.28 per share or (y) the lowest exercise price of any securities that have been issued by us in a capital raising transaction (and that would otherwise reduce the exercise price of any other outstanding warrants issued by us) during the period between November 15, 2016 and the date of the delivery of the Election Notice. No capital raising transactions have occurred through the date of this filing with securities at a price lower than $0.28 per share.                
IthenaPharma Inc [Member]                  
Common stock, issued 58,392,828                
Ownership percentage of issued and outstanding shares 65.00%             65.00%  
Warrants to purchase shares 300,000                
Maximum percentage of subsequent to the merger 50.00%                
Purchase price of reserve merger consideration $ 3,700,000                
IthenaPharma Inc [Member] | Related Party [Member]                  
Investment 479                
Accounts payable 71,560                
Accrued expenses 11,470                
Due to related party 5,375                
Other liabilities 118,759                
Convertible note 50,000                
Accrued Interest Payable 567                
Contributed capital $ 257,252                
Novosom Verwaltungs GmbH [Member] | Asset Purchase Agreement [Member]                  
Issuance of common stock, shares 1,500,000                
Issuance of common stock, value           $ 15,000      
Novosom Verwaltungs GmbH [Member] | License Agreement [Member]                  
Issuance of common stock, shares         119,048        
Issuance of common stock, value         $ 15,000